Literature DB >> 18543555

Results of surgical treatment for lung cancer in young adults.

Takeshi Hanagiri1, Kenji Sugio, Hidetaka Uramoto, Masakazu Sugaya, Kenji Ono, Tetsuya So, Yoshinobu Ichiki, Shoji Nakata, Tadahiro Nozoe, Toshihiro Osaki, Kosei Yasumoto.   

Abstract

In this study, we evaluated the results of surgical treatment in young adults and compared the clinico-pathological features between young and elderly patients. We reviewed the clinical records of 1185 lung cancer patients who underwent surgery in our department. A total of 20 (1.7%) primary lung cancer patients (14 men and 6 women) < or =40 years of age were retrieved. The age range was from 26 to 40 years. Histological type included 10 adenocarcinomas (50%), 3 large cell carcinomas (15%), 3 carcinoids (15%), 2 squamous cell carcinomas (10%), and 2 others. The surgical procedure included 7 (35%) pneumonectomies, 11 (55.0%) lobectomies, and 1 (5%) partial resection. The proportion of pneumonectomies was significantly higher than among elderly patients. Clinical stage was underestimated in 7 of 20 patients, and among these, mediastinal lymph node metastases were revealed by pathological examination in 6 patients. Postoperative 5-year survival rates were 50.2%, 50.4%, and 43.8% in patients < or =40, 41-70, and > or =71 years old, respectively. There were no significant differences in survival rates between younger group and elderly groups. This study suggests that surgical resection is also recommended as the first-line treatment for younger patients with lung cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18543555

Source DB:  PubMed          Journal:  Int Surg        ISSN: 0020-8868


  4 in total

1.  Clinicopathological characteristics and treatment strategies for young lung cancer patients.

Authors:  Remi Yoneyama; Hisashi Saji; Yasufumi Kato; Yujin Kudo; Yoshihisa Shimada; Masakazu Kimura; Masaru Hagiwara; Masatoshi Kakihana; Kuniharu Miyajima; Naohiro Kajiwara; Tatsuo Ohira; Harubumi Kato; Norihiko Ikeda
Journal:  Ann Transl Med       Date:  2019-03

2.  [Clinical analysis of lung cancer patients younger than 30 years].

Authors:  Guangjie Hou; Lianbin Zhang; Xiangyang Chu; Jiyun Wang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-05

3.  [Efficacy of gefitinib for young patients with unknown EGFR gene mutation 
in advanced lung adenocarcinoma].

Authors:  Yutao Liu; Yuankai Shi; Xingsheng Hu; Xuezhi Hao; Junling Li; Ziping Wang; Yan Wang; Hongyu Wang; Xiangru Zhang; Yan Sun
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-05

4.  Epidemiology and prognosis in young lung cancer patients aged under 45 years old in northern China.

Authors:  Jin Shi; Daojuan Li; Di Liang; Yutong He
Journal:  Sci Rep       Date:  2021-03-25       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.